Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02534415
Other study ID # YU-351
Secondary ID
Status Completed
Phase Phase 4
First received August 17, 2015
Last updated August 25, 2015
Start date August 2013
Est. completion date August 2015

Study information

Verified date August 2015
Source Marmara University
Contact n/a
Is FDA regulated No
Health authority Turkey: Ethics Committee
Study type Interventional

Clinical Trial Summary

Aim of the study is to assess the therapeutic effects of topical hyaluronic-acid use on secondary wound healing of the free gingival graft donor site. The hypothesis of this study is that topical hyaluronic-acid gel has positive effects on secondary wound healing of free gingival graft donor site by reducing pain, burning sensation, and accelerating the healing.


Description:

The objective of the randomized, single blind, controlled and parallel clinical trial was to assess therapeutic effects of topical hyaluronic-acid on secondary wound healing of free gingival graft donor site.

Primary outcome variables that pain and burning sensation changes were assessed at 3, 7, 14, 21 days after surgery by the examiner. Pain and burning sensation were assessed by patients using the VAS, score 0 indicate no pain or burning sensation, score 10 indicate severe pain or burning sensation. Secondary outcome variables included color match, consistency and epithelization of the wound area. These parameters were assessed by the same examiner at 3, 7, 14, 21 and 42 days after surgery. Color of the palatal mucosa was assessed by comparing it to that of the adjacent and opposite site using the VAS. Score 0 indicate no color match and score 10 indicate very good color match. Consistency of the palatal mucosa was assessed with a blunt instrumentation and scored as soft or firm. Epithelialization was scored clinically as none, partial or complete.

Sample size has been estimated in 12 subjects per treatment groups. Random allocation of the treatment sites to test and control groups will be performed using a computerized selection of random numbers for allocation of the study groups.

Clinical images obtained at baseline, 3, 7, 14, 21 and 42 days after surgery from each treatment site.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date August 2015
Est. primary completion date July 2015
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Good general health

- No periodontal surgical treatment in the previous 6 months on the involved sites

Exclusion Criteria:

- Smoking

- Patients with a pregnancy or lactation period

- Self-reported history of antibiotic medication within three months

- Absence of tooth in the area of donor site

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Drug:
Periodontal dressing material
Procedure:Palatal wound area was covered with periodontal dressing material at baseline and 3rd day
0.2% Hyaluronic acid gel
0.2% topical hyaluronic-acid gel was applied to palatal wound area and covered with periodontal dressing material (Peripac®) at baseline and 3rd day
0.8% Hyaluronic acid gel
0.8% topical hyaluronic-acid gel was applied palatal wound area and covered with periodontal dressing material (Peripac®) at baseline and 3rd day

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Marmara University

Outcome

Type Measure Description Time frame Safety issue
Primary Pain Using a visual analog scale (0: No pain, 10: Severe pain) 21 days No
Secondary Color match Using a visual analog scale (0: No color match, 10: Good color match) (Adjacent and opposite site) 42 days No
Secondary Consistency Soft/firm 42 days No
Secondary Epithelialisation None/partial/complete 42 days No
Secondary Burning Sensation Using a visual analog scale (0: No burning sensation, 10: Severe burning sensation) 21 days No
See also
  Status Clinical Trial Phase
Terminated NCT03010137 - Incisional Negative Pressure Wound Therapy in High Risk Patients Undergoing Panniculectomy: A Prospective Randomized Controlled Trial N/A